Envista (NYSE:NVST) Reaches New 1-Year Low at $30.98

Shares of Envista Holdings Co. (NYSE:NVST) reached a new 52-week low on Thursday . The company traded as low as $30.98 and last traded at $30.99, with a volume of 26892 shares trading hands. The stock had previously closed at $31.38.

Wall Street Analyst Weigh In

NVST has been the subject of a number of recent analyst reports. Bank of America dropped their price target on Envista from $47.00 to $45.00 in a report on Tuesday, July 11th. TheStreet cut Envista from a “b” rating to a “c+” rating in a report on Friday, June 9th. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $45.50.

Envista Price Performance

The company has a 50 day moving average price of $33.67 and a 200 day moving average price of $35.42. The company has a market capitalization of $5.02 billion, a price-to-earnings ratio of 25.51, a PEG ratio of 1.81 and a beta of 1.42. The company has a current ratio of 1.29, a quick ratio of 1.04 and a debt-to-equity ratio of 0.20.

Envista (NYSE:NVST) last released its earnings results on Wednesday, August 2nd. The company reported $0.43 EPS for the quarter, beating the consensus estimate of $0.41 by $0.02. The company had revenue of $662.40 million during the quarter, compared to analysts’ expectations of $655.81 million. Envista had a return on equity of 7.60% and a net margin of 8.40%. The business’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period last year, the firm earned $0.48 EPS. As a group, equities research analysts forecast that Envista Holdings Co. will post 1.86 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in NVST. Raymond James & Associates boosted its position in shares of Envista by 6.1% in the 1st quarter. Raymond James & Associates now owns 56,493 shares of the company’s stock worth $2,752,000 after purchasing an additional 3,235 shares during the last quarter. Bank of Montreal Can boosted its position in shares of Envista by 13.9% in the 1st quarter. Bank of Montreal Can now owns 124,799 shares of the company’s stock worth $6,103,000 after purchasing an additional 15,228 shares during the last quarter. Panagora Asset Management Inc. boosted its position in shares of Envista by 8.1% in the 1st quarter. Panagora Asset Management Inc. now owns 6,543 shares of the company’s stock worth $319,000 after purchasing an additional 490 shares during the last quarter. Great West Life Assurance Co. Can lifted its holdings in Envista by 8.6% during the first quarter. Great West Life Assurance Co. Can now owns 88,474 shares of the company’s stock worth $4,433,000 after acquiring an additional 7,020 shares in the last quarter. Finally, Vontobel Holding Ltd. bought a new position in Envista during the first quarter worth about $390,000.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.